ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Translational Session

Prospects for Gene Therapy in Glomerular Disease, Including the Michelle P. Winn, MD, Endowed Lectureship

November 03, 2022 | 10:30 AM - 12:30 PM

Location: W320 Chapin, Orange County Convention Center‚ West Building

Session Description

This session reviews developments in the clinical translation of gene therapies and considers challenges for the development of gene therapy in glomerular disease.

ASN gratefully acknowledges Duke University School of Medicine, the school's Division of Nephrology, and several individuals for support of the Michelle P. Winn, MD, Endowed Lectureship.

Learning Objective(s)

  • Discuss recent developments in the field of gene therapies
  • Describe challenges for gene therapy in kidney diseases
  • Outline options for clinical trials of gene therapy in kidney diseases

Learning Pathway(s)

  • Glomerular Diseases
  • Genetic Diseases and Development


  • Friedhelm Hildebrandt, MD
  • Kandai Nozu, MD, PhD


  • Experience from Clinical Trials of Immune Gene Therapies
    10:30 AM - 11:00 AM
    Waseem Qasim, MBBS, PhD
  • Targeting the Kidneys with Gene Therapy
    11:00 AM - 11:30 AM
    Matthew H. Wilson, MD, PhD
  • Adeno-Associated Virus (AAV) Genome Rescue of Nphs2 in Mice: The Michelle P. Winn, MD, Endowed Lectureship
    11:30 AM - 12:00 PM
    Moin Saleem, MBBS, MBChB, MD, PhD
  • Preclinical Gene Therapy Studies in Alport Syndrome Dogs
    12:00 PM - 12:30 PM
    Mary B. Nabity, PhD, DVM